LONDON, May 27 (Reuters) - The world's first life-saving
gene therapy for children, developed by GlaxoSmithKline
and Italian scientists, was approved for sale in Europe on
Friday, in a step forward for the pioneering technology to fix
faulty genes.
Read more
No comments:
Post a Comment